Christina Ackermann Verona Pharma PLC (VRNA) insider trading activity

Christina Ackermann is Director of Verona Pharma plc. Currently has a direct ownership of 64,072 shares of VRNA, which is worth approximately $6.74 Million. The most recent transaction as insider was on Aug 01, 2025, when has been sold 1,808 shares (Ordinary Shares) at a price of $13.14 per share, resulting in proceeds of $23,757. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 64.1K

52.99% 3M change

n/a 12M change

Total Value Held $6.74 Million

CHRISTINA ACKERMANN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2025	SELL Open market or private sale	$23,757 $13.14 p/Share	1,808 Reduced 2.74%	64,072 Ordinary Shares
Aug 01 2025	BUY Exercise of conversion of derivative security	-	24,000 Added 26.7%	65,880 Ordinary Shares
May 14 2025	SELL Open market or private sale	$337,600 $8.44 p/Share	40,000 Reduced 48.85%	41,880 Ordinary Shares
May 14 2025	BUY Exercise of conversion of derivative security	$77,200 $1.93 p/Share	40,000 Added 32.82%	81,880 Ordinary Shares
Nov 06 2024	BUY Open market or private purchase	$198,511 $4.74 p/Share	41,880 Added 50.0%	41,880 Ordinary Shares

Also insider at

BHC

Bausch Health Companies Inc. Healthcare

EVP AND GENERAL COUNSEL

GRAY

GRAYBUG VISION, INC. Healthcare

Director

BLCO

Bausch & Lomb Corp Healthcare

Officer